Comparison of a vasopeptidase inhibitor with neutral endopeptidase and angiotensin-converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed

Journal of Cardiovascular Pharmacology

Volumn 37, Issue 4, 2001, Pages 359-366

  Dumoulin, M J ^a   Adam, A ^a   Rouleau, J L ^a   Lamontagne, D ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

ACE inhibitors; Bradykinin; Heart; Ischemia; Metabolism; NEP inhibitors

Indexed keywords

BRADYKININ; CANDOXATRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRILAT; ENKEPHALINASE INHIBITOR; MEMBRANE METALLOENDOPEPTIDASE; OMAPATRILAT; QUINAPRIL; RAMIPRIL; RETROTHIORPHAN; VASOPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE ISCHEMIA; ISOLATED HEART; MALE; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; HEART; MALE; METALLOENDOPEPTIDASES; MYOCARDIUM; NEPRILYSIN; PROTEASE INHIBITORS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; THIAZEPINES; TIME FACTORS;

EID: 0035083665     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200104000-00002     Document Type: Article

References (25)

1. 9]BK: Influence of enalaprilat
2. Metabolism of bradykinin by the rat coronary vascular bed
3. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: An interspecies study
4. Bradykinin-degrading enzymes: Structure, function, distribution, and potential roles in cardiovascular pharmacology
5. Bradykinin metabolism in the postinfarcted rat heart: Role of ACE and neutral endopeptidase 24.11
6. 9-bradykinin using a chemiluminescence enzyme immunoassay: Application to its kinetic profile during plasma activation
7. Development of digoxigenin-labelled peptide: Application to chemilumino-enzyme immunoassay of bradykinin in inflamed tissues
8. Assay of peptidase and protease enzymes in vivo
9. Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung
10. The chemistry and pharmacology of cell-surface peptidase inhibitors
11. Mechanisms of the natriuretic effects of neutral endopeptidase inhibition in Dahl salt-sensitive and salt-resistant rats
12. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones
13. Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides
14. Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: Possible physiological significance
15. Effect of inhibition of endopeptidase 24.11 on responses to angiotensin II in human volunteers
16. Characterization of neutral endopeptidase in vascular cells, modulation of vasoactive peptide levels
17. Neutral endopeptidase-24.11 inhibitors: From analgesics to antihypertensives?
18. Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption
19. Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist
20. Effect of neutral endopeptidase 24.11 inhibition on myocardial ischemia/reperfusion injury: The role of kinins
21. Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme
22. Effects of omapatrilat in low, normal, and high renin experimental hypertension
23. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure
24. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure
25. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure